Metabolomics Profiling of Gestational Diabetes
Author Information
Author(s): Aleidi Shereen M., Al Fahmawi Hiba, AlMalki Reem H., Al Mogren Maha, Alwahsh Mohammad, Mujammami Muhammad, Costanzo Michele, Abdel Rahman Anas
Primary Institution: The University of Jordan
Hypothesis
This study aims to investigate the metabolic profile associated with gestational diabetes mellitus (GDM) through untargeted metabolomic analysis.
Conclusion
The study identified 222 human endogenous metabolites significantly dysregulated in women with GDM, highlighting key metabolic pathways that could be targeted for early screening and intervention.
Supporting Evidence
- 222 metabolites were significantly dysregulated in GDM patients compared to controls.
- Key metabolic pathways such as tryptophan and histidine metabolism were altered in GDM.
- N-Acetylproline and Serylmethionine showed high accuracy in distinguishing between GDM and non-GDM women.
Takeaway
This study looked at blood samples from pregnant women to find out how their metabolism changes with gestational diabetes, helping doctors diagnose it earlier.
Methodology
The study used mass spectrometry-based untargeted metabolomic analysis on serum samples from pregnant women diagnosed with GDM and matched controls.
Potential Biases
Potential biases may arise from the single-center design and the specific demographic of the participants.
Limitations
The study was limited by a small sample size from a single hospital, which may affect the generalizability of the findings.
Participant Demographics
Pregnant women aged 18–40 years at weeks 24–28 of gestation, with 20 diagnosed with GDM and 20 as controls.
Statistical Information
P-Value
<0.001
Confidence Interval
0.898–1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website